Literature DB >> 26903174

The effectiveness of nasal surgery on psychological symptoms in patients with obstructive sleep apnea and nasal obstruction.

Yang Xiao1, Demin Han1, Hongrui Zang1, Danni Wang1.   

Abstract

Conclusion Nasal obstruction can aggravate the psychological status of OSA patients, and nasal surgery should reduce this aggravation. Nasal surgery significantly improved sleep latency and ameliorated several polysomnographic characteristics. Background The aim of this study was to investigate the psychological status of patients with obstructive sleep apnea (OSA) and nasal obstruction and to evaluate the effects of nasal surgery on the psychological symptoms and polysomnographic (PSG) parameters of these patients. Methods The study was designed as a prospective comparative study. This study compared 30 patients (all male) with nasal obstruction and 30 matched patients without nasal obstruction using the Pittsburgh Sleep Quality Index (PSQI) and the Symptom Check List 90 (SCL-90). All of the patients had been previously diagnosed with OSA (apnea hypopnea index [AHI] ≥ 5 events/h) via a whole-night polysomnographic examination. Nasal obstruction was assessed using a visual analogue scale (VAS). The patients with nasal obstruction underwent nasal surgery, and their weight, VAS, nocturnal PSG characteristics, and psychological symptoms at baseline and 3 months after surgery were compared. Results The OSA patients with nasal obstruction suffered from significantly longer sleep latency on the PSQI and higher somatization and anxiety scores on the SCL-90 than the subjects without nasal obstruction (p < 0.05). The nasal obstruction symptoms significantly improved after surgery (VAS decreased from 6.18 ± 1.85 to 1.87 ± 1.76, p < 0.01). The assessments also showed a significant reduction in weight (from 84.60 ± 11.30 kg to 82.27 ± 9.87 kg, p < 0.05) between the pre-operative and post-operative values. Although there was significant reduction in the AHI (from 49.67 ± 19.49/h to 43.07 ± 21.86/h, p < 0.01) and a significant improvement in lowest oxygen saturation (LSpO2, from 73.83 ± 8.49% to 75.97 ± 9.86%, p < 0.05), only 23.3% of patients achieved a response of nasal surgery that met Sher's criteria. Remarkable reductions were observed in the sleep latency scores, daytime dysfunction scores on the PSQI, anxiety and hostility scores, and the number of positive symptoms on the SCL-90 (p < 0.05). There was a strong positive correlation between PSQI total score and some psychosomatic symptoms on the SCL-90, including inter-personal sensitivity, depression, hostility, paranoid ideation, psychoticism, global symptom index, and the number of positive symptoms (r > 0.3, p < 0.05).

Entities:  

Keywords:  Psychological symptoms; nasal obstruction; nasal surgery; obstructive sleep apnea

Mesh:

Year:  2016        PMID: 26903174     DOI: 10.3109/00016489.2016.1143120

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Functional Nasal Surgery and Use of CPAP in OSAS Patients: Our Experience.

Authors:  Domenico Michele Modica; Donatella Marchese; Francesco Lorusso; Riccardo Speciale; Carmelo Saraniti; Salvatore Gallina
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-31

Review 2.  [Treating nasal obstruction in obstructive sleep apnea patients].

Authors:  T Verse; S Wenzel
Journal:  HNO       Date:  2017-02       Impact factor: 1.284

Review 3.  Apnea-hypopnea index decreased significantly after nasal surgery for obstructive sleep apnea: A meta-analysis.

Authors:  Jun Wu; Guoqiang Zhao; Yunchuan Li; Hongrui Zang; Tong Wang; Dongbo Wang; Demin Han
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

4.  Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  David Kent; Jeffrey Stanley; R Nisha Aurora; Corinna G Levine; Daniel J Gottlieb; Matthew D Spann; Carlos A Torre; Katherine Green; Christopher G Harrod
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.